成釉细胞瘤中尿激酶型纤溶酶原激活物(uPA)、尿激酶型纤溶酶原激活物受体(uPAR)、纤溶酶原激活物抑制剂-1(PAI-1)和乳腺丝抑蛋白(maspin)的免疫组织化学检测
Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
作者信息
Kumamoto H, Ooya K
机构信息
Division of Oral Pathology, Department of Oral Medicine and Surgery, Tohoku University Graduate School of Dentistry, Sendai, Japan.
出版信息
J Oral Pathol Med. 2007 Sep;36(8):488-94. doi: 10.1111/j.1600-0714.2007.00554.x.
BACKGROUND
To evaluate the roles of extracellular matrix (ECM)-degrading serine proteinase in progression of odontogenic tumors, expression of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), plasminogen activator inhibitor-1 (PAI-1), and maspin was analyzed in ameloblastic tumors as well as in tooth germs.
METHODS
Tissue specimens of 10 tooth germs, 45 ameloblastomas, and 5 malignant ameloblastic tumors were examined immunohistochemically with the use of antibodies against uPA, uPAR, PAI-1, and maspin.
RESULTS
Immunohistochemical reactivity for uPA, uPAR, PAI-1, and maspin was detected in normal and neoplastic odontogenic tissues: uPA was recognized predominantly in mesenchymal cells, uPAR was evident in epithelial cells, PAI-1 was found in both epithelial and mesenchymal cells, and maspin was expressed only in epithelial cells. The levels of uPA and uPAR immunoreactivity in ameloblastic tumors were slightly higher than the levels in tooth germs, while PAI-1 reactivity in ameloblastomas tended to be lower than that in tooth germs. The level of maspin immunoreactivity in ameloblastomas was significantly higher than that in tooth germs, and ameloblastic carcinoma showed decreased maspin reactivity.
CONCLUSION
Expression of uPA, uPAR, PAI-1, and maspin in tooth germs and ameloblastic tumors suggests that interactions among these molecules contribute to ECM degradation and cell migration during tooth development and tumor progression. Altered expression of the serine proteinase and its associated molecules in ameloblastic tumors may be involved in oncogenesis of odontogenic epithelium.
背景
为评估细胞外基质(ECM)降解丝氨酸蛋白酶在牙源性肿瘤进展中的作用,我们分析了尿激酶型纤溶酶原激活剂(uPA)、uPA受体(uPAR)、纤溶酶原激活剂抑制剂-1(PAI-1)和乳腺丝抑蛋白在成釉细胞瘤以及牙胚中的表达情况。
方法
使用抗uPA、uPAR、PAI-1和乳腺丝抑蛋白的抗体,对10个牙胚、45个成釉细胞瘤和5个恶性成釉细胞瘤的组织标本进行免疫组织化学检查。
结果
在正常和肿瘤性牙源性组织中检测到uPA、uPAR、PAI-1和乳腺丝抑蛋白的免疫组织化学反应:uPA主要在间充质细胞中被识别,uPAR在上皮细胞中明显,PAI-1在上皮和间充质细胞中均有发现,而乳腺丝抑蛋白仅在上皮细胞中表达。成釉细胞瘤中uPA和uPAR免疫反应性水平略高于牙胚中的水平,而成釉细胞瘤中PAI-1反应性往往低于牙胚中的反应性。成釉细胞瘤中乳腺丝抑蛋白免疫反应性水平显著高于牙胚中的水平,而成釉细胞癌显示乳腺丝抑蛋白反应性降低。
结论
uPA、uPAR、PAI-1和乳腺丝抑蛋白在牙胚和成釉细胞瘤中的表达表明,这些分子之间的相互作用有助于牙齿发育和肿瘤进展过程中的ECM降解和细胞迁移。成釉细胞瘤中丝氨酸蛋白酶及其相关分子的表达改变可能参与牙源性上皮的肿瘤发生。